Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jeffrey F. Miller
University of California Los Angeles, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
AvidBiotics Corp
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Miller is the PI has disclosed that he is a co-founder of AvidBiotics, Corp, is a voting member of the Board of Directors, and is chair of the Scientific Advisory Board. He holds equity. AvidBiotics also supported his travel to three Scientific Advisory Boards during the past year. Additionally, he is the inventor of Intellectual Property owned by The Regents and licensed on an exclusive basis to AvidBiotics. The licensed IP is not being used in this study. However, per Professor Miller this IP involves the use of Diversity-Generating Retroelements (DGRs) for the directed evolution of proteins with desired ligand-binding specificities. DGRs were discovered in his UCLA laboratory and have potential applications that include therapeutics and diagnostics. The focus of the grant is understanding DRGs to reveal new mechanisms for accelerated evolution by bacteria and phage and to provide new paradigms for understanding adaptations of importance to human health and disease. Professor Miller and a colleague at UC San Diego share responsible for the direction of this study. Professor Miller is the contact Principal Investigator.
Diversity-Generation and Variable Protein Displays in Pathogens and Phage
Our studies will contribute to an understanding of a newly discovered mechanism that is widely used by bacteria and bacteriophage to generate massive amounts of protein diversity to accelerate the evolution of adaptive traits. Our proposed experiments involve important pathogens belonging to the Bordetella and Legionella genera.
Filed on April 18, 2013.
Tell us what you know about Jeffrey F. Miller's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jeffrey F. Miller”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jeffrey F. Miller | University of California Los Angeles | Conflict of Interest | AvidBiotics Corp | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.